COSMETIC COMPOSITION FOR CARE OF KERATIOUS MATERIAL

Abstract

COSMETIC COMPOSITION FOR CARE OF KERATIOUS MATERIAL The present invention relates to a composition for care of keratinous material, in particular an anti-aging and anti-glycation composition, preferably in the form of an oil-in-water emulsion, comprising (a) silicone elastomers, including (a1) at least one emulsifying silicone elastomer, and (a2) at least one non-emulsifying silicone elastomer; (b) at least one silicone oil; and (c) at least one active agent, which preferably includes water-soluble active ingredients, wherein the weight ratio between the emulsifying silicone elastomer and the non-emulsifying silicone elastomer varies from 1:35 to 1:10, preferably from 1:30 to 1:15, or from 1:28 to 1:20. Figure for abstract: none

Description

Description Title of the invention: COSMETIC CARE COMPOSITION OF keratinous material Technical field

[0001] — The present invention relates to a cosmetic care composition of material ké- ratineuse, and in particular an anti-aging and anti-glycation composition. RELATED ART

[0002] = Anti-glycation means resisting the glycation reaction which is one of the factors of human aging and dull skin, and prevent and / or reduce glycation of skin proteins, especially dermal proteins, such as collagen. glycation of collagen will lead to protein hardening, fiber breakage, a loss of skin elasticity and, finally, wrinkles, leading to sagging skin; glycation of keratin will make the skin rough and dull and it will lose its humidity.

[0003] — During the aging process, different signs appear on the skin at as a result of a change in skin structure and function. One clinical signs of aging include, among others, the appearance of fine wrinkles and deep wrinkles. These signs of aging increase with age. A disorganization nization of the "texture" of the skin is more particularly observed, which means that the microcontours are less regular and have an anisotropic character.

[0004] It is known to treat these signs of aging using cos- metic or dermatological products containing active ingredients suitable for combating these signs aging, such as proxylane, collrepair and vitamin C derivatives. These active ingredients act mainly on wrinkles by eliminating dead skin cells and accelerating the cell renewal process.

[0005] = However, active ingredients, particularly water-soluble active ingredients, cause often a stickiness and / or unpleasant feeling during application and leave a film that is not smooth, soft or without moisture on the skin. There is therefore a need to improve the sensation on the skin during and after the application of cos- metics comprising said active ingredients.

[0006] …— The inventor discovers that when cosmetics, e.g. oil-in-water emulsions water include silicone elastomers, improved skin feel can be achieved by adjusting the ratio of emulsifying elastomer to non-emulsifying elastomer emulsifier and adding one or more specific silicone oils.

[0007] — Thanks to the specific ratio between the emulsifying elastomer and the non-emulsifying elastomer emulsifier and the addition of silicone oils, cosmetics including anti-active ingredients aging and anti-glycation, especially water-soluble actives, have a good feeling of non-sticky nature during and after application, and a moister skin finish, and leaving a soft film on the skin. Summary of the invention According to the first aspect, the present invention relates to a keratinous material care composition, in particular an anti-aging and anti-glycation composition, preferably in the form of an oil-in-water emulsion, comprising (a) silicone elastomers, including (a1) at least one emulsifying silicone elastomer, and (a2) at least one non-emulsifying silicone elastomer; (b) at least one silicone oil; and (c) at least one active agent. In one embodiment, the active includes water-soluble active ingredients, or consists substantially of water-soluble active ingredients, or even consists of water-soluble active ingredients. In one embodiment, the active includes an amount of about 1% by weight or less of non-water-soluble active ingredients, based on the total weight of the composition. In one embodiment, the composition substantially does not include oil-soluble active ingredients, or even does not include oil-soluble active ingredients. In one embodiment, said at least one silicone oil comprises a first silicone oil and / or a second silicone oil, and the non-emulsifying silicone elastomer is present as a mixture with the first silicone oil before being added to the composition and / or the emulsifying silicone elastomer is present as a mixture with the second silicone oil before being added to the composition, the first silicone oil being the same as the second silicone oil or different from the second silicone oil. Preferably, said at least one silicone oil further comprises a third silicone oil, and the third silicone oil is the same as the first and / or the second silicone oil or different from both. In one embodiment, the weight ratio of emulsifying silicone elastomer to non-emulsifying silicone elastomer ranges from about 1:35 to about |:10, preferably from about 1:30 to about |:15, or from about 1:28 to about |:20. The emulsifying silicone elastomer is chosen from silicone elastomers comprising at least one oxyalkylenated chain and / or at least one glyceryl chain. Non-emulsifying silicone elastomer includes dimethicone crosspolymer, vinyl dimethicone crosspolymer, dimethicone / vinyl dimethicone crosspolymer, dimethicone-3 crosspolymer, or mixtures thereof. The silicone oil is chosen from linear, branched or cyclic silicones, fa- optionally modified with at least one organofunctional moiety or group, including polyether-modified silicones. The active ingredient is selected from C-Glycoside compounds, plant extracts, peptides, flavonoids, vitamin C and its derivatives, hyaluronic acid and its salts, or mixtures thereof. Due to the specific ratio between the emulsifying elastomer and the non-emulsifying elastomer and the addition of said silicone oils, the compositions comprising said actives have a good feeling of non-stickiness during and after application, and a soft moisturizing finishing film on the skin. In one embodiment, the composition of the present invention further comprises water, and the water is present in an amount ranging from about 25 wt% to about 90 wt%, preferably from about 30 wt% to about 85 wt%, or from about 40 wt% to about 80 wt%, based on the total weight of the composition. According to the second aspect, the present invention relates to a combination for improving the feeling on the skin during and after the application of a cosmetic, comprising, consisting substantially of, or even consisting of (a) silicone elastomers, including (a1) at least one emulsifying silicone elastomer, and (a2) at least one non-emulsifying silicone elastomer, and (b) at least one silicone oil. In one embodiment, the weight ratio of emulsifying elastomer to non-emulsifying elastomer ranges from about 1:35 to about 1:10, preferably from about 1:30 to about 1:15, or from about 1:28 to about 1:20. In one embodiment, the active preferably includes, or consists substantially of, water-soluble active ingredients, or even consists of water-soluble active ingredients, and includes C-Glycoside compounds, plant extracts, peptides, flavonoids, vitamin C and its derivatives, or mixtures thereof. According to the third aspect, the present invention relates to a process for caring for keratinous materials, for example skin, in particular the skin around the eyes, by applying the composition of the present invention to the skin, and optionally massaging the skin, According to the fourth aspect, the present invention relates to the use of a combination for improving the feeling on the skin during and after the application of a cosmetic, wherein the combination is as defined above. Other subjects and features, aspects and advantages of the present invention will become even more apparent from the detailed description and examples which follow. DETAILED DESCRIPTION OF THE INVENTION As used herein, unless otherwise stated, the limits of a range of values ​​are included in this range, especially in the expressions “between…and…” and “from…to>”. The articles “a” and “an,” as used herein, mean one or more when applied to any feature in embodiments of the present invention described in the specification and claims. The use of “a” and “an” does not limit the meaning to a single feature unless such a limitation is specifically stated. Furthermore, the expression “at least one” as used in this specification is equivalent to the expression “one or more.” Throughout this application, the term "comprising" should be interpreted to encompass all of the specifically mentioned features as well as optional, additional, unspecified features. As used herein, the use of the term "comprising" also discloses the embodiment in which no material features other than the specifically mentioned features are present (such as "consisting substantially of" or "consisting of"). In the case of "consisting substantially of," any additional composition, material, and / or component that materially affects the fundamental and novel features is excluded from such an embodiment, but any composition, material, and / or component that does not materially affect the fundamental and novel features may be included in the embodiment. The term "about" denoting a certain value is intended to denote a range within +5% of the value. For example, the expression "about 100" denotes a range of 100 + 5, i.e., the range from 95 to 105. In general, when the term "about" is used, it can be expected that similar results or effects according to the disclosure can be obtained within +5% of the stated value. As used herein, the term "keratinous material" refers to skin, nails, or mucous membranes, and, in at least one embodiment, refers to skin. Silicone elastomers The composition of the present invention comprises elastomers organopolysiloxane, also called “silicone elastomers” in the remainder of the description, preferably which are at least partially crosslinked. The term "elastomer" means a flexible, deformable solid material with viscoelastic properties, particularly the consistency of a sponge or soft sphere. Its modulus of elasticity is such that this material resists deformation and has a limited capacity to expand and contract. This material is capable of returning to its original shape after being stretched. This elastomer is formed from high-molecular-weight polymer chains, the mobility of which is limited by a uniform network of crosslinking points. The organopolysiloxane elastomers used in the composition of the present invention are preferably partially or totally crosslinked. They are in the form of particles. These particles can have any shape, for example, they can be spherical, flat or amorphous. When included in an oil phase, these organopolysiloxane elastomers transform, depending on the content of oil phase used, into a spongy-looking product when used in the presence of small amounts of oil phase, or into a homogeneous gel in the presence of larger amounts of oil phase. The gelling of the oil phase with these elastomers can be total or partial. Thus, the elastomers of the present invention can be supplied in the form of an anhydrous gel consisting of an organopolysiloxane elastomer and an oil phase. The oil phase used in the manufacture of the anhydrous organopolysiloxane elastomer gel contains one or more oils which are liquid at room temperature (25°C) selected from hydrocarbon oils and / or silicone oils. Advantageously, the oily phase is a liquid silicone phase, containing one or more oils chosen from polydimethylsiloxanes containing a linear or cyclic chain, which are liquid at room temperature, optionally comprising a pendant or terminal alkyl or aryl chain. The silicone elastomers used according to the present invention may be chosen from the crosslinked polymers described in patent application EP-A-0 295 886 and from those described in patent US-A-5 266 321. Non-emulsifying silicone elastomers The term "non-emulsifying silicone elastomers" or "non-emulsifying organopolysiloxane elastomers" defines organopolysiloxane elastomers that do not contain a hydrophilic chain such as polyoxyalkylene or polyglycerolated units. Preferably, the organopolysiloxane elastomer is a crosslinked organopolysiloxane elastomer which can be obtained: - by addition reaction by crosslinking of a diorganosiloxane containing at least one hydrogen bonded to silicon and of a polyoxyalkylene having at least two ethylenically unsaturated groups; - by addition reaction by crosslinking of a diorganopolysiloxane containing at least one hydrogen bonded to silicon and of a diorganopolysiloxane having ethylenically unsaturated groups bonded to silicon, in particular in the presence of a platinum catalyst; - by addition reaction by crosslinking of a diorganosiloxane containing at least one hydrogen bonded to silicon and of a diorganopolysiloxane having ethylenically unsaturated groups bonded to silicon, in particular in the presence of an organosiloxane compound tannic; - by crosslinking condensation reaction by dehydrogenation between a diorganopolysiloxane having hydroxyl end groups and a diorganopolysiloxane containing at least one hydrogen bonded to silicon, in particular in the presence of an organostannic compound; - by condensation reaction by crosslinking of a diorganopolysiloxane having hydroxyl end groups and a hydrolyzable organopolysilane; - by thermal crosslinking of an organopolysiloxane, in particular in the presence of an organoperoxide catalyst; and - by crosslinking an organopolysiloxane by high energy radiation such as gamma rays, ultraviolet rays or an electron beam. Preferably, the crosslinked organopolysiloxane elastomer is obtained by addition reaction by crosslinking: of a compound (A) of a diorganopolysiloxane containing at least two hydrogen atoms each bonded to a different silicon atom, and of a compound (B) of a diorganopolysiloxane having at least two ethylenically unsaturated groups bonded to silicon, in particular in the presence of a platinum catalyst (C), as described, for example, in application EP-A-295 886. In particular, the organopolysiloxane can be obtained by reacting a dimethylpolysiloxane having dimethylvinylsiloxy end groups and a methylhydrogenpolysiloxane having trimethylsiloxy end groups, in the presence of a platinum catalyst. Compound (A) is the basic reactant for the formation of an organopolysiloxane elastomer and crosslinking is carried out by an addition reaction of compound (A) with compound (B) in the presence of catalyst (C). Compound (A) is advantageously a diorganopolysiloxane having at least two lower alkenyl groups (e.g. C1-C12); the lower alkenyl group may be chosen from vinyl, allyl and propylene groups. These lower alkenyl groups can be located at any position on the organopolysiloxane molecule but are preferably located at the ends of the organopolysiloxane molecule. The organopolysiloxane (A) can have a branched chain, a straight chain, a cyclic or a network structure, but the straight chain structure is preferred. Compound (A) can have a viscosity ranging from a liquid to a gum state. Preferably, compound (A) has a viscosity of at least 100 centistokes at 25°C. The organopolysiloxanes (A) may be chosen from methylvinylsiloxanes, methylvinylsiloxane / dimethylsiloxane copolymers, dimethylpolysiloxanes having dimethylvinylsiloxy end groups, dimethylsiloxane / methylphenylsiloxane having dimethylvinylsiloxy end groups, dimethylsiloxane / diphenylsiloxane / methylvinylsiloxane copolymers having dimethylvinylsiloxy end groups, dimethylsiloxane / methylvinylsiloxane copolymers having dimethylvinylsiloxy end groups, dimethylsiloxane / methylphenylsiloxane / methylvinylsiloxane copolymers having dimethylvinylsiloxy end groups, methyl (3,3,3-trifluoropropyl) polysiloxanes having dimethylvinylsiloxy end groups and dimethylsiloxane / methyl (3,3,3-trifluoropropyl) siloxane copolymers having dimethylvinylsiloxy end groups. Compound (B) is, in particular, an organopolysiloxane having at least two hydrogens bonded to silicon in each molecule and is therefore the crosslinking agent of compound (A). Advantageously, the sum of the number of ethylenic groups per molecule of compound (A) and the number of hydrogen atoms bonded to silicon per molecule of compound (B) is at least 4. Compound (B) may have any molecular structure, including a straight-chain or branched-chain structure or a cyclic structure. Compound (B) may have a viscosity, at 25°C, ranging from 1 to 50,000 centistokes, in particular in order to be highly miscible with compound (A). It is advantageous if the compound (B) is added in such an amount that the molecular ratio of the total amount of silicon-bonded hydrogen atoms in the compound (B) to the total amount of all ethylenically unsaturated groups in the compound (A) is between 1 / 1 and 20 / 1. Compound (B) may be selected from methylhydrogenpolysiloxanes having trimethylsiloxy end groups, dimethylsiloxane / methylhydrogensiloxane copolymers having trimethylsiloxy end groups and cyclic dimethylsiloxane / methylhydrogensiloxane copolymers. Compound (C) is the catalyst for the crosslinking reaction, and is in particular chloroplatinic acid, chloroplatinic acid / olefin complexes, chloroplatinic acid / alkenylsiloxane complexes, chloroplatinic acid / diketone complexes, platinum black and supported platinum. Other organic groups may be bonded to silicon in the organopolysiloxanes (A) and (B) described above, such as, for example, alkyl groups such as methyl, ethyl, propyl, butyl or octyl groups; substituted alkyl groups such as 2-phenylethyl, 2-phenylpropylene or 3,3,3-trifluoropropyl; aryl groups such as phenyl, tolyl or xyl groups; substituted aryl groups such as a phenylethyl group; and substituted monovalent hydrocarbon groups such as an epoxy group, a carboxylate ester group or a mercapto group. In particular, the non-emulsifying silicone elastomer used in the present invention is selected from Dimethicone Crosspolymer (INCI name), Vinyl Dimethicone Crosspolymer (INCI name), Dimethicone / Vinyl Dimethicone Crosspolymer (INCI name), Dimethicone Crosspolymer-3 (INCI name), and mixtures thereof. In some embodiments, the silicone elastomer may be delivered as a gel formed from an elastomeric organopolysiloxane included in at least one of hydrocarbon oil and / or silicone oil. In these gels, the organopolysiloxane particles are often non-spherical particles. Non-emulsifying elastomers are described in particular in patents EP 242 219, EP 285 886 and EP 765 656. The silicone elastomer is generally supplied in gel, paste or powder form, but preferably in gel form in which the silicone elastomer is dispersed in a linear silicone oil (dimethicone) or cyclic silicone oil (e.g. cyclopentasiloxane), preferably in a linear silicone oil. Non-emulsifying elastomers which may be more particularly used include those sold under the names KSG-6, KSG-15, KSG-16, KSG-18, KSG-41, KSG-42, KSG-43 and KSG-44 by Shin-Etsu Company, DC9040 and DC9041 by Dow Corning and SFE 839 by General Electric Company. According to a particular embodiment, use is made of a silicone elastomer gel dispersed in a silicone oil chosen from a non-exhaustive list comprising cyclopentadimethylsiloxane, dimethicones, dimethylsiloxanes, methyl trimethicone, phenyl methicone, phenyl dimethicone, phenyl trimethicone and cyclomethicone, preferably a linear silicone oil chosen from polydimethylsiloxanes (PDMS) or dimethicones with a viscosity at 25°C ranging from 1 to 500 cSt, optionally modified with optionally fluorinated aliphatic groups, or with functional groups such as hydroxyl, thiol and / or amine groups. Particular mention may be made of compounds bearing the following INCI names: dimethicone / vinyl dimethicone crosspolymer, such as USG-105 and USG-107A from Shin-Etsu; DC9506 and DC9701 from Dow Corning; dimethicone / vinyl dimethicone crosspolymer (and) dimethicone, such as KSG-6 and KSG-16 from Shin-Etsu; dimethicone / vinyl dimethicone crosspolymer (and) cyclopentasiloxane, such as KSG-15; cyclopentasiloxane (and) dimethicone crosspolymer, such as DC9040, DC9045 and DC5930 from Dow Corning; dimethicone (and) dimethicone crosspolymer, such as DC9041 from Dow Corning. dimethicone (and) dimethicone crosspolymer, such as Dow Corning EL-9240 Silicone Elastomer Blend from Dow Corning (a blend of polydimethylsiloxane crosslinked with hexadiene / polydimethylsiloxane (2 cSt)); C424 alkyl dimethicone / divinyl dimethicone crosspolymer, such as NuLastic Silk MA from Alzo. Mention may in particular be made, as examples of silicone elastomers dispersed in a linear silicone oil which can advantageously be used according to the present invention, of the following references: dimethicone / vinyl dimethicone crosspolymer (and) dimethicone, such as KSG-6 and KSG-16 from the company Shin-Etsu; dimethicone (and) dimethicone crosspolymer, such as DC9041, Dow Coming EL-9240 Silicone Elastomer Blend from the company Dow Corning. Organopolysiloxane elastomer particles can also be used in powder form: mention may be made in particular of the powders sold under the names Dow Corning 9505 Powder and Dow Corning 9506 Powder by the Dow Corning company, powders having the INCI name: dimethicone / vinyl dimethicone crosspolymer. The organopolysiloxane powder may also be coated with silsesquioxane resin, as described, for example, in U.S. Patent No. 5,538,793. These elastomeric powders are sold under the names KSP-100, KSP-101, KSP-102, KSP-103, KSP-104 and KSP-105 by Shin-Etsu and bearing the INCI name: vinyl dimethicone / methicone silsesquioxane crosspolymer. As examples of organopolysiloxane powders coated with silsesquioxane resin which can advantageously be used according to the present invention, mention may be made in particular of the reference KSP-100 from the company Shin-Etsu. As a preferred lipophilic gelling agent of the organopolysiloxane elastomer type, particular mention may be made of crosslinked organopolysiloxane elastomers selected from Dimethicone Crosspolymer (INCI name), Dimethicone (and) Dimethicone Crosspolymer (INCI name), [Vinyl Dimethicone Crosspolymer (INCI name), DimethiconeNinyl Dimethicone Crosspolymer (INCI name), Dimethicone Crosspolymer-3 (INCD name. It is preferable that the non-emulsifying silicone elastomers are selected from dimethicone / vinyldimethicone crosslinked polymer, dimethicone crosslinked polymer and mixtures thereof. According to a preferred embodiment, the silicone elastomers bearing the INCI name dimethicone / vinyldimethicone copolymer (or polysilicone-11) are used in a mixture with linear or cyclic silicone oil. According to the present invention, the non-emulsifying silicone elastomer is present in an amount ranging from about 0.01% by weight to about 40% by weight, preferably from about 1% by weight to about 30% by weight, or from about 5% by weight to about 25% by weight, based on the total weight of the composition. Emulsifying silicone elastomers The term "emulsifier" from "emulsifying silicone elastomer" means that silicone elastomer is capable of emulsifying or has an emulsifying function. The emulsifying silicone elastomer of the present invention may be a crosslinked elastomeric organopolysiloxane comprising at least one hydrophilic chain, knowing that this chain may in particular be oxyalkylenated or glyceryl. The emulsifying silicone elastomer may therefore be chosen from silicone elastomers comprising at least one oxyalkylenated chain and / or at least one glyceryl chain. It is preferable that the emulsifying silicone elastomer comprises at least one silicone polymer crosslinked with at least one hydrophilic moiety. The hydrophilic moiety may comprise at least one polyoxyalkylene chain and / or at least one polyglyceryl chain. The silicone elastomer comprising at least one oxyalkylenated chain can be obtained in particular by addition reaction and crosslinking of a diorganopolysiloxane containing at least two hydrogens each linked to a silicon (A1), and of a polyoxyalkylene having at least two ethylenically unsaturated groups (B1), in particular in the presence of a catalyst (C1), in particular a platinum catalyst, as described for example in documents US patent No. 5,236,986 and US patent No. 5,412,004. Compound (A1) is the base compound for the formation of elastomeric organopolysiloxane, and crosslinking takes place via an addition reaction of compound (A1) with compound (B1) in the presence of catalyst (C1). Compound (B1) is advantageously an oxyethylenated and / or oxypropylenated compound containing at least two vinyl groups in the a-co position of the silicone chain, which will react with Si-H bonds of compound (A1). Compound (B1) may in particular be a polyoxyalkylene (in particular polyoxyethylene and / or polyoxypropylene) containing dimethylvinylsiloxy end groups. The organic groups bonded to the silicon atoms of compound (A1) may be alkyl groups containing 1 to 18 carbon atoms, such as methyl, ethyl, propyl, butyl, octyl, decyl, dodecyl (or lauryl), myristyl, cetyl or stearyl; substituted alkyl groups such as 2-phenylethyl, 2-phenylpropyl or 3,3,3-trifluoropropyl; aryl groups such as phenyl, tolyl or xylyl; substituted aryl groups such as phenylethyl; and substituted monovalent hydrocarbon groups such as an epoxy group, a carboxylate ester group or a mercapto group. Compound (A1) may therefore be chosen from methylhydrogenpolysiloxanes containing trimethylsiloxy end groups, dimethylsiloxane-methylhydrogensiloxane copolymers containing trimethylsiloxy end groups, cyclic dimethylsiloxane-methylhydrogensiloxane copolymers and dimethylsiloxane-methylhydrogensiloxanelaurylmethyl-siloxane copolymers containing trimethylsiloxy end groups. Compound (C1) is the crosslinking reaction catalyst, and is in particular chosen from chloroplatinic acid, chloroplatinic acid-olefin complexes, chloroplatinic acid-alkenylsiloxane complexes, chloroplatinic acid-diketone complexes, platinum black and platinum on a support. In particular, the silicone elastomer comprising at least one oxyalkylenated chain can be obtained by reaction of polyoxyalkylene (in particular polyoxyethylene and / or polyoxypropylene) containing dimethylvinylsiloxy end groups and methylhydrogenpolysiloxane containing trimethylsiloxy end groups, in the presence of a platinum catalyst. The silicone elastomer comprising at least one oxyalkylenated chain, used according to the present invention, is preferably a silicone elastomer comprising at least one oxyethylenated chain. Furthermore, the silicone elastomer comprising at least one oxyalkylenated chain is preferably carried in the form of a gel in at least one hydrocarbon oil and / or one silicone oil. Thus, the emulsifying silicone elastomer can take the form of a gel. In these gels, the elastomer comprising at least one oxyalkylenated chain is generally in the form of non-spherical particles. Polyoxyalkylenated silicone elastomers have been particularly described in U.S. Patent No. 5,236,986, U.S. Patent No. 5,412,004, U.S. Patent No. 5,837,793, and U.S. Patent 5,811,487, the contents of which are incorporated by reference. As silicone elastomers comprising at least one oxyethylenated chain, use may be made in particular of those sold by the company Shin Etsu under the names of Dimethicone / PEG-10 Dimethicone vinyl dimethicone crosspolymer, such as that sold under the name KSG-21 (at 27% in terms of active ingredient), PEG-10 Dimethicone Crosspolymer, such as that sold under the name KSG-20 (100% active ingredient, Dimethicone / PEG-10 / 15 crosspolymer, such as that sold as KSG-210 (25% silicone elastomer active in silicone oil), Cyclopentasiloxane (and) Dimethicone / PEG-10 / 15 crosspolymer, such as that sold under the name KSG-240, Mineral oil (and) PEG-15 / lauryl dimethicone crosspolymer, such as that sold under the name KSG-310, Isododecane (and) PEG-15 / lauryl dimethicone crosspolymer, such as that sold as KSG-320, Isododecane (and) PEG-15 / lauryl polydimethylsiloxyethyl dimethicone crosspolymer, such as that sold under the name KSG-320Z, Cyclopentasiloxane (and) PEG-15 / lauryl polydimethylsiloxyethyl dimethicone crosspolymer, such as that sold as KSG-350Z, Dimethicone (and) PEG-15 / auryl polydimethylsiloxyethyl dimethicone crosspolymer, such as those sold under the names KSG-360Z and KSG-380Z (25-45% in terms of silicone elastomer active ingredient in silicone oil), or those sold by the Dow Corning Company under the names PEG-12 dimethicone crosspolymer, such as that sold under the name DC9010 (at 11% active ingredient), and Cyclopentasiloxane (and) PEG-12 Dimethicone crosspolymer such as that sold as DC9011 (91% active ingredient). These products are usually in the form of oily gels containing silicone elastomer particles. It is best to use Dimethicone / PEG-10 / 15 crosspolymer, such as that sold as KSG-210, PEG / 15 lauryl dimethicone crosspolymer, such as that sold as KSG-320, and PEG-15 / lauryl polydimethylsiloxyethyl dimethicone crosspolymer, such as that sold as KSG-380Z. The emulsifying silicone elastomer may also be chosen from silicone elastomers comprising at least one glyceryl chain. The silicone elastomer comprising at least one glyceryl chain can be obtained in particular by addition reaction and crosslinking of a diorganopolysiloxane containing at least one hydrogen bonded to silicon (A2) and of a polyglyceryl compound having ethylenically unsaturated groups (B2), in particular in the presence of a catalyst (C2), in particular a platinum catalyst. In particular, the organopolysiloxane can be obtained by reacting a polyglyceryl compound containing dimethylvinylsiloxy end groups and methylhydrogenpolysiloxane containing trimethylsiloxy end groups, in the presence of a platinum catalyst. Compound (A2) is the base compound for the formation of elastomeric organopolysiloxane, and crosslinking takes place via an addition reaction of compound (A) with compound (B2) in the presence of catalyst (C2). Compound (A2) is in particular an organopolysiloxane having at least two hydrogen atoms bonded to separate silicon atoms in each molecule. Compound (A2) may have a viscosity at 25°C, ranging from 1 to 50,000 centistokes, in particular so as to be easily miscible with compound (B2). The organic groups bonded to the silicon atoms of compound (A2) may be alkyl groups containing from 1 to 18 carbon atoms, such as methyl, ethyl, propyl, butyl, octyl, decyl, dodecyl (or lauryl), myristyl, cetyl or stearyl; substituted alkyl groups such as 2-phenylethyl, 2-phenylpropyl or 3,3,3-trifluoropropyl; aryl groups such as phenyl, tolyl or xylyl; substituted aryl groups such as phenylethyl; and substituted monovalent hydrocarbon groups such as an epoxy group, a carboxylate ester group or a mercapto group. Preferably, said organic group is selected from methyl, phenyl and lauryl groups. Compound (A2) may therefore be chosen from methylhydrogenpolysiloxanes containing trimethylsiloxy end groups, dimethylsiloxane-methylhydrogensiloxane copolymers containing trimethylsiloxy end groups, cyclic dimethylsiloxane-methylhydrogensiloxane copolymers and dimethylsiloxane-methylhydrogensiloxane-laurylmethylsiloxane copolymers containing trimethylsiloxy end groups. Compound (B2) may be a polyglycerolated compound corresponding to formula (B'2) below: CrHam-1-0-[Giy]n-CmHam-1 (B'2) in which m is an integer ranging from 2 to 6, n is an integer ranging from 2 to 200, preferably from 2 to 100, preferentially from 2 to 50, better still from 2 to 20, still better still from 2 to 10, and still better still from 2 to 5, and in particular n is equal to 3; and Gly denotes: CH-CH(OH)-CH2-0- or -CH:-CH(CH20H)-0- Advantageously, the sum of the number of ethylenic groups per molecule of compound (B2) and the number of hydrogen atoms bonded to silicon atoms per molecule of compound (A2) is at least 4. It is advantageous if the compound (A2) is added in such an amount that the molecular ratio of the total amount of hydrogen atoms bonded to silicon atoms in the compound (A2) to the total amount of all ethylenically unsaturated groups in the compound (B2) is in the range of 1 / 1 to 20 / 1. Compound (C2) is the crosslinking reaction catalyst, and is in particular chosen from chloroplatinic acid, chloroplatinic acid-olefin complexes, chloroplatinic acid-alkenylsiloxane complexes, chloroplatinic acid-diketone complexes, platinum black and platinum on a support. The catalyst (C2) is preferably added in an amount of 0.1 to 1,000 parts by weight, more preferably 1 to 100 parts by weight, as clean platinum metal, per | 000 parts by weight of the total amount of compounds (A2) and (B2). The silicone elastomer comprising at least one glyceryl chain, used according to the present invention, is generally in the form of a gel mixed with at least one hydrocarbon oil and / or a silicone oil. In these gels, the elastomer comprising at least one glyceryl chain is commonly in the form of non-spherical particles. These elastomers are described in particular in document WO-A-2004 / 024798. As a silicone elastomer comprising at least one glyceryl chain, use may be made of those sold by the company Shin Etsu under the names of Dimethicone / Polyglycerin-3 Crosspolymer, such as that sold as KSG-710 (containing 25% active ingredient), Mineral oil (and) Lauryl dimethicone / polyglycerin-3 crosspolymer, such as that sold as KSG-810, Isododecane (and) Lauryl dimethicone / polyglycerin-3 crosspolymer, such as that sold under the name KSG-820, Triethylhexanoin (and) Lauryl dimethicone / polyglycerin-3 crosspolymer, such as that sold as KSG-830, and Squalane (and) Laury! dimethicone / polyglycerin-3 crosspolymer, such as that sold as KSG-840. 1 it is preferable that the emulsifying silicone elastomer is chosen from silicone elastomers comprising at least one oxyalkylenated chain and / or at least one glyceryl chain, and more preferably a silicone elastomer comprising at least one oxyethylenated chain. According to the present invention, the emulsifying silicone elastomer is present in an amount ranging from about 0.01% by weight to about 5% by weight, preferably from about 0.1% by weight to about 3% by weight, or from about 0.2% by weight to about 2% by weight relative to the total weight of the composition. Silicone oils Here, the term "oil" means a fatty compound or substance that is in the form of a liquid or paste at room temperature (25 °C) under atmospheric pressure (760 mmHg). As silicone oils, those generally used in cosmetics can be used alone or in combination. The silicone oil(s) may be selected from volatile silicones, non-volatile silicones and mixtures thereof. Thus, the silicone oil may comprise at least one volatile silicone oil or at least one non-volatile silicone oil, or both at least one volatile silicone oil and at least one non-volatile silicone oil. The volatile or non-volatile silicone may be selected from linear, branched or cyclic silicones, optionally modified with at least one organofunctional moiety or group. For example, the silicone oil may be selected from the group consisting of polydialkylsiloxanes such as polydimethylsiloxanes (PDMS), polyalkylaryl-siloxanes such as phenyltrimethicone, polydiarylsiloxanes, and polysiloxanes organomodified oils comprising at least one organofunctional moiety or group selected from poly(oxyalkylene) moieties or groups, alkoxy or alkoxyalkyl moieties or groups, hydroxyl or hydroxylated moieties or groups, acyloxy or acyloxyalkyl moieties or groups, carboxylic acid or carboxylate moieties or groups, acrylic moieties or groups, and oxazoline moieties. If the silicone oil(s) is (are) volatile, the silicone oil(s) may be selected from those with a boiling point ranging from 60°C to 260°C, for example: l cyclic silicones such as polydialkylsiloxanes comprising from 3 to 7, for example, 4 to 5 silicon atoms. Non-limiting examples of these siloxanes include commercially available octamethylcyclotetrasiloxane, for example example, under the trade name VOLATILE SILICONE® 7207 by UNION CARBIDE and SILBIONE® 70045 V2 by RHODIA, decamethyl- cyclopentasiloxane marketed under the trade name VOLATILE SILICONE® 7158 by UNION CARBIDE, and SILBIONE® 70045 V5 by RHODIA, KF-995 by SHIN ETSU, as well as their mixtures. Cyclomethicone- Thicones can also be used, for example, those commercially available under the references DC 244, DC 245, DC 344, DC 345 and DC 246 by DOW CORNING. Cyclocopolymers of the dimethylsiloxane / methylalkyl- type Siloxane can also be used, such as SILICONE VOLATILE® FZ 3109 marketed by UNION CARBIDE, with the formula in which: ÿ* 15 From F0 aud are CH C3 From —if-—2 CeH;7 Combinations of cyclic silicones such as polydialkylsiloxanes with organic silicon-derived compounds may also be used, such as a mixture of octamethylcyclotetrasiloxane and tetramethylsilylpentaerythritol (50 / 50), and a mixture of octamethylcyclotetrasiloxane and oxy-1,1"-(hexa-2,2,2',2',3,3"-trimethylsilyloxy) bisneopentane; and (ii) linear volatile polydialkylsiloxanes comprising from 2 to 9 silicon atoms. A non-limiting example of such a compound is decamethyltetrasiloxane marketed, for example, under the trade name “SH-200” by TORAY SILICONE. Furthermore, the silicone oil(s) may be chosen from non- volatile, such as polydialkylsiloxanes, polyalkylarylsiloxanes, polydiarylsiloxanes and organomodified polysiloxanes. The molecular weight of the silicone, preferably polydimethylsiloxanes with trimethylsilyl end groups, has an average molecular weight (M,,) of 300,000 or more, preferably 350,000 or more, more preferably 400,000 or more, and preferably 3,000,000 or less, more preferably 2,000,000 or less, even more preferably 1,000,000 or less. According to one embodiment, the silicone oil may be selected from non-volatile polydialkylsiloxanes, for example, polydimethylsiloxanes with trimethylsilyl end groups known under the trade name dimethicone. The preferred silicone oil according to the present invention may be polydimethylsiloxanes with trimethylsilyl end groups, such as oils having a viscosity at 25°C greater than 1,000,000 cSt (mm” / s), even more preferably a viscosity greater than 2,000,000 cSt, and even more particularly greater than 5,000,000 cSt, more preferably greater than 10,000,000 cSt and preferably less than 50,000,000 cSt, more preferably less than 30,000,000 cSt, still more preferably less than 15,000,000 cSt. According to the present invention, all polydimethylsiloxanes can be used as such or in the form of solutions, emulsions, nanoemulsions or microemulsions. Non-limiting examples of commercial products corresponding to these polydialkylsiloxanes include BY22-029 (product of Dow Corning Toray, Co., Ltd.; non-ionic emulsion of dimethicone oil), BY22-060 (product of Dow Corning Toray, Co., Ltd.; cationic emulsion containing a solution obtained by diluting highly polymerized dimethicone with a low-viscosity silicone), BY22-019 (product of Dow Corning Toray, Co., Ltd.; non-ionic and cationic emulsion containing a solution obtained by diluting highly polymerized dimethicone with cyclic silicone), BY22-020 (product of Dow Corning Toray, Co., Ltd.; cationic emulsion containing a solution obtained by diluting highly polymerized dimethicone with light liquid isoparaffin), KM902 (product of Shin-Etsu Chemical Co. Ltd; non-ionic emulsion containing a solution obtained by diluting highly polymerized dimethicone with a low-viscosity silicone), BY22-030 (product of Dow Corning Toray, Co., Ltd.; non-ionic emulsion containing a solution obtained by diluting highly polymerized dimethicone with a low-viscosity silicone), BY22-040 (product of Dow Corning Toray, Co., Ltd.; non-ionic emulsion containing a solution obtained by diluting highly polymerized dimethicone with a low-viscosity silicone), BY22-050 (product of Dow Corning Toray, Co., Ltd.; non-ionic emulsion containing a solution obtained by diluting highly polymerized dimethicone with a low-viscosity silicone), BY22-060 (product of Dow Corning Toray, Co., Ltd.; non-ionic emulsion containing a solution obtained by diluting highly polymerized dimethicone with a low-viscosity silicone), BY22-070 (product of Dow Corning Toray, Co., Ltd.; non-ionic emulsion containing ionic of highly polymerized dimethicone), KM903 (product of Shin-Etsu Chemical Co., Ltd.; cationic emulsion containing a solution obtained by diluting highly polymerized dimethicone with a low-viscosity silicone), X-52-2127 (product of Shin-Etsu Chemical Co., Ltd.; cationic emulsion containing a solution obtained by diluting highly polymerized dimethicone with a low-viscosity silicone), X-52-2162 (product of Shin-Etsu Chemical Co., Ltd.; non-ionic emulsion containing a solution obtained by diluting highly polymerized dimethicone with a low-viscosity silicone), EMU101 (product of Momentive Performance Materials, Inc.; non-ionic emulsion containing . a solution obtained by diluting highly polymerized dimethicone with a low viscosity silicone), XS65-B3803 (product of Momentive Performance Materials, Inc.; non-ionic emulsion containing a solution obtained by diluting highly polymerized dimethicone with a low viscosity silicone), DC 7-3100 (product of Dow Corning Toray Silicone, Co., Ltd.). The polyalkylarylsiloxanes can be chosen from polydimethyl / methylphenylsiloxanes, linear and / or branched polydimethyl / diphenyl siloxanes. Non-limiting examples of such polyalkylarylsiloxanes include products marketed under the following trade names: SILBIONE® fluids from the 70 641 range from RHODIA; RHODORSIL® fluids from the 70 633 and 763 ranges from RHODIA; the phenyltrimethicone fluid marketed under the reference DOW CORNING 556 COSMETIC GRADE FLUID by DOW CORNING; silicones from the BAYER PK range, for example the PK20 product; BAYER PN and PH range silicones, for example, PN1000 and PH 1000 products; and certain GENERAL ELECTRIC SF range fluids, such as SF 1023, SF 1154, SF 1250 and SF 1265. Organomodified silicones that may be used according to the present invention include, but are not limited to, silicones as defined above and comprising at least one organofunctional moiety or group linked directly or by means of a hydrocarbon group within their structure. The organomodified silicones may include, for example, polyorganosiloxanes comprising: polyethyleneoxy and / or polypropyleneoxy moieties optionally comprising Cs-C4 alkyl moieties, such as the products called dimethicone copolyols marketed by DOW CORNING under the trade name DC 1248 and under the trade name DC Q2-5220 and SILWET® L 722, L 7500, L 77, and fluids L 711 marketed by UNION CARBIDE and (Ci2) alkyl-methicone copolyol marketed by DOW CORNING under the trade name Q2 5200; alkoxylated fractions, such as the product marketed under the trade name "SILICONE COPOLYMER F-755" by SWS SILICONES and ABIL WAX® 2428, 2434, and 2440 by GOLDSMIDT; hydroxylated fractions, such as the polyorganosiloxanes containing a hydroxyalkyl function described; for example, the polyorganosiloxanes described in U.S. Patent No.4,957,732; anionic fractions of carboxylic acid Lype, for example, the products described in European Patent No. 0 186 507, marketed by CHISSO CORPORATION, and anionic alkyl carboxylic fractions, such as those present in the product X-22-3701E marketed by SHIN-ETSU; 2-hydroxyalkyl sulfonate; and 2-hydroxyalkyl thiosulfate such as the products marketed by GOLDSCHMIDT under the . trade names “ABIL® S201” and “ABIL® S255”; acrylic fractions, such as products marketed under the names VS80 and VS70 by 3M; and oxazoline fractions -CR-CRN: +, De=s0 + CH, The silicones that can be used according to the present invention may comprise 1 or 2 oxazoline groups; for example, poly(2-methyl oxazoline-b-dimethyl siloxane-b-2-methyl oxazoline) and poly(2-ethyl-2-oxazoline-dimethyl] siloxane). The products marketed by KAO under the references OX-40, OS-51, OS-96, and OS-88 may also be used. Polydimethylsiloxanes with dimethylsilanol end groups may also be used, for example, those sold under the trade name dimethiconol (CTFA), such as the 48 range fluids marketed by RHODIA. If the silicone oil(s) is / are volatile, the silicone oil(s) may be chosen from polydimethylsiloxanes and organomodified polydimethylsiloxanes, It is preferable that the silicone oil is selected from volatile or non-volatile silicone oils, such as volatile or non-volatile polydimethylsiloxanes (PDMS) containing a linear or cyclic silicone chain, which are liquid or pasty at room temperature, in particular cyclopolydimethylsiloxanes (cyclomethicones) such as cyclopentasiloxane and cyclohexasiloxane; polydimethylsiloxanes containing alkyl, alkoxy, or phenyl groups which are pendant and / or at the end(s) of the silicone chain, which groups have from 2 to 24 carbon atoms; phenyl silicones such as phenyl trimethicones, phenyldimethicones, phenyltrimethylsiloxydiphenylsiloxanes, diphenylmethyldiphenyltrisiloxanes, 2-phenylethyltrimethyl siloxysilicates and polymethylphenylsiloxanes; and organomodified silicones such as dimethiconol. It is possible to use a combination of silicone oils. Non-limiting examples of such combinations include a mixture of cyclopentasiloxane and dimethiconol, marketed, for example, under the trade name Xiameter PMX-1501 Fluid by Dow Corning, and a mixture of dimethicone and dimethiconol, for example, under the trade name MIRASIL D-DML LV A2 by Elkem Silicones. On the other hand, the silicone oil or oils may be selected from polysiloxanes comprising at least one terminal or pendant monovalent polyoxyalkylene group, which may be classified as polyoxyalkylene-modified silicones or polyether-modified silicones. Polysiloxanes can be polydimethylsiloxane. Polyoxyalkylene-modified silicones or polyether-modified silicones can be represented by formula (1): R:S1O(R2:S10),(RPESIO),SiR?; (1) in which: the radicals R?, which are identical or different, denote a monovalent hydrocarbon radical chosen from alkyl, aryl and aralkyl radicals having at most 10 carbon atoms; p varies from 0 to 150, preferably from 0 to 100 and more preferably from 0 to 30; q varies from | to 12, preferably from 1 to 10 and more preferably from | to 8; the polyether group PE corresponds to the following formula (2): -C,H2,(OC2H4) (OC:H;),OR3 (2) in which: X varies from | to 8 and preferably varies from 2 to 4 and is more preferably equal to 3; y is greater than Ô; Zz is greater than or equal to 0; the values ​​of y and z being such that the total molecular weight of the polyoxyalkylene portion of the polyether group PE varies from 200 to 10,000 and more preferably from 350 to 4,000; R° denotes hydrogen, a C1-C2 alkyl group; or a C7-C2 acyl group. It should be noted that when z is different from O, the polyoxyethylene and polyoxypropylene units may be randomly distributed along the polyether PE chain or distributed in sequences or distributed both in sequences and randomly. Preferably, the radicals R? are chosen from C1-C3 alkyl groups; and hexyl, phenyl and benzyl groups. More particularly, the radicals R? are chosen from alkyl groups, such as methyl, ethyl or butyl groups. More particularly, they denote the methyl radical. Preferably, the radicals R* are chosen from C1-C4 alkyl groups and more particularly denote the methyl radical. Polyether-modified silicones of formula (1) can be obtained according to the process described in US Patent No. 4,847,398. It is preferable to use, among the polyether-modified silicones of formula (1), those of the following formula (1): Me;SiIO(MeSi0),(MePES10),SiMez (1) in which p and q have the same values ​​as given above for formula (1), Me denotes the methyl radical, and PE means: -(CH,);(OC,H4) (OC,H;5),OR; (2) Or y and z have the same values ​​as given above for formula (2), and R° denotes hydrogen or a C1-C2 alkyl group; and more particularly the methyl radical. Mention may be made, as other families of polyether-modified silicones which may be used according to the present invention, of the branched silicones of the following formula (3): (MeSi0),-2[SiOMez),OPE], (3) where p and q have the same values ​​as those indicated above in formula (1), Me means methyl and PE denotes the group of formula (4) following: -(OC,H4) (OC,H5),R° (4) Or y and z have the same values ​​as given above in formula (2), and R* denotes a C1-C3 alkyl group, and more particularly the methyl radical. It is of course possible to use a mixture of silicones of formula (1) and formula (3). These silicones modified for polyether are sold, for example, by OSI under the commercial names Silwet L-7210® (INCI name: Dimethicone Copolyol), Silwet L- 7220® (INCI name: Diméthicone Copolyol) ; Silwet L-7002®, Silwet L-7600® (INCI name: Dimethicone Copolyol), Silwet L-7604® (INCI name: PEG-8 Dimethicone), Silwet L-7605®, Silwet L-7607®, Silwet 1614, Silwet L-7657®, Silwet L-7200® (name INCI: Dimethicone Copolyol), Silwet L-7230®, Silsoft 305® (INCI name: Dimethicone Copolyol), Silsoft 820® (INCI name: Dimethicone Copolyol), Silsoft 880® (INCI name: PEG-12 Dimethicone), XIAMETER OFX-0193 (INCI name: PEG-12 Dimethicone), methicone) available also from Dow Corning, FLUID Tego Wet 260®, Tego Wet 500®, Tego Wet 505® and Tego Wet 510®. Examples of polyether-modified silicones include PEG-10 methyl ether dimethicone, PEG-11 methyl ether dimethicone, PEG-32 methyl ether dimethicone, PEG / PPG-18 / 18 dimethicone, PEG / PPG-19 / 19 dimethicone, PEG / PPG-20 / 20 dimethicone, PEG / PPG-20 / 22 butyl ether dimethicone, PEG / PPG-30 / 10 dimethicone, PEG-9 dimethicone, PEG-10 dimethicone, PEG-12 dimethicone, and mixtures thereof. In one embodiment, PEG-11 methyl ether dimethicone is combined with PPG-5-buteth-5, for example, under the trade name KF 351 A from Shin Etsu. In one embodiment, the silicone oils may be selected from polyether-modified silicone derivatives. The water-soluble silicone derivative may be a water-soluble silicone in which at least one substituent is bonded to the polysiloxane backbone of the water-soluble silicone, preferably instead of a methyl group on the polydimethylsiloxane backbone. As a substituent, there may be mentioned, for example, an alkyl group, an alkenyl group, an alkoxyl group, an amino group and a hydroxyl group. The alkyl group may be a straight, branched or cyclic alkyl group. The alkyl group may be a straight or branched C1-C2 alkyl group, preferably a C1-C3 alkyl group, such as a methyl group, an ethyl group, a propyl group, an i-propyl group and a butyl group. On the other hand, the alkyl group may be a cyclic C1-C2 alkyl group, such as a cyclopentyl group and a cyclohexyl group. The alkenyl group may be a C,-C alkenyl group; such as a vinyl group, an allyl group, a butylene group, a pentenyl group and a hexenyl group. The alkoxy group may be a C,-Cs alkoxy group such as a methoxy group, an ethoxy group and a propoxy group. The above substituent may be further substituted with at least one group such as a halogen atom, an amino group, a nitro group, a cyano group, a hydroxyl group and an aromatic group such as a phenyl group. Examples of polyether-modified silicone derivatives include cetyl PEG / PPG-10 / 1 dimethicone, lauryl PEG / PPG-18 / 18 methicone and mixtures thereof. In one embodiment, the composition of the present invention comprises more than one silicone oil, and one of the silicone oils is selected from polyether-modified silicones. In one embodiment, the composition of the present invention comprises dimethicones, dimethiconols, and polyether-modified silicones as silicone oils. According to the present invention, the silicone oil is present in an amount ranging from about 5% by weight to about 50% by weight, preferably from about 15% by weight to about 40% by weight, or from about 18% by weight to about 30% by weight, based on the total weight of the composition. Assets The composition of the present invention comprises at least one active ingredient, which preferably includes water-soluble active ingredients, consisting substantially of, or even consisting of, water-soluble active ingredients. The active ingredients are selected from C-Glycoside compounds, plant extracts, peptides, flavonoids, vitamin C and its derivatives, hyaluronic acid and its salts, or mixtures thereof. C-Glycoside Compounds In particular, the composition of the present invention may comprise at least one C-Glycoside compound, in particular of the following general formula: SUOx—R - R represents a saturated C, to Cp, in particular C, to C4 alkyl radical which may optionally be substituted by at least one radical chosen from OH, COOH or COOR", R", being a saturated C,-C4 alkyl radical, - S represents a monosaccharide or a polysaccharide comprising up to 20 sugar units, in particular up to 6 sugar units, in the form of pyranose and / or furanose and of the L and / or D series, said monosaccharide or polysaccharide possibly being substituted by a hydroxyl group which is necessarily free and optionally one or more protected amine functional groups, and - X represents a radical chosen from the groups —-CO-, -CH(OH)-, -CH(NH>)-, - CH(NHCH.CH.CH.OH)-, -CH(NHPh)- and —-CH(CH;)- and in particular a radical -CO-, -CH(OH)- or -CH(NH.)- and more particularly a radical -CH(OH)-, the S-CHz-X bond represents a C-anomeric bond, which can be A or PB, as well as their physiologically acceptable salts, their solvates, such as hydrates and their optical and geometric isomers. The C-glycosides used for the implementation of the invention are in particular those for which R denotes a saturated linear alkyl radical of C, to C5, in particular of C, to C,, preferably of C, to C; and better still, a methyl radical. Among the alkyl groups suitable for implementing the invention, mention may in particular be made of methyl, ethyl, isopropyl, n-propyl, n-butyl, t-butyl, isobutyl, sec-butyl, pentyl, n-hexyl, cyclopropyl, cyclopentyl or cyclohexyl groups. According to one embodiment of the invention, it is possible to use a C-Glycoside corresponding to formula (I) for which S can represent a monosaccharide or a polysaccharide comprising up to 6 sugar units, in the form of pyranose and / or furanose and of L and / or D series, said monosaccharide or polysaccharide having at least one free hydroxyl functional group and / or optionally one or more necessarily protected amine functional groups, X and R moreover retaining all the definitions above. Advantageously, a monosaccharide of the invention may be selected from the following elements: D-glucose, D-galactose, D-mannose, D-xylose, D-lyxose or L-fucose, L-arabinose, L-rhamnose, D-glucuronic acid, D-galacturonic acid, D-iduronic acid, N-acetyl-D-glucosamine or N-acetyl-D-galactosamine and advantageously denotes the following elements: D-glucose, D-xylose, N-acetyl-D-glucosamine or L-fucose and in particular D-xylose. More particularly, a polysaccharide of the invention comprising up to 6 sugar units may be chosen from D-maltose, D-lactose, D-cellobiose, D-maltotriose, a disaccharide combining a uronic acid chosen from D-iduronic acid or D-glucuronic acid with a hexosamine chosen from D-galactosamine, D-glucosamine, N-acetyl-D-galactosamine or N-acetyl-D-glucosamine, an oligosaccharide comprising at least one xylose which may advantageously be chosen from xylobiose, methyl-B-xylobioside, xylotriose, xylotetraose, xylopentaose and xylohexaose, and in particular xylobiose, which is composed of two xylose molecules linked via a 1-4 bond. More particularly, S may represent a monosaccharide chosen from D-glucose, D-xylose, L-fucose, D-galactose or D-maltose and in particular D-xylose. Preferably, a C-glycoside of formula (I) is used for which: - R denotes an unsubstituted linear alkyl radical, C, - C4c, in particular a C, - C, alkyl radical, in particular a methyl radical; - S represents a monosaccharide as described above and selected in particular from D-glucose, D-xylose, N-acetyl-D-glucosamine or L-fucose, and in particular D-xylose; - X represents a group chosen from a -CO-, -CH(OH)- or -CH(NH;) group and, preferably, a -CH(OH)- group. Acceptable salts of the compounds described in the present invention include conventional non-toxic salts of said compounds, such as those formed from organic or inorganic acids. Examples include salts of inorganic acids such as sulfuric acid, hydrochloric acid. Also included are salts of organic acids, which may comprise one or more carboxylic, sulfonic or phosphonic acid groups. Examples include propionic acid, acetic acid, terephthalic acid, citric acid and tartaric acid. When the compound of formula (I) comprises an acid group, the neutralization of the acid group(s) may be carried out with an inorganic base, such as LiOH, NaOH, KOH, Ca(OH),, NH,OH, Mg(OH). or Zn(OH),, or with an organic base, such as a primary, secondary or tertiary alkylamine, for example triethylamine or butylamine. This primary, secondary or tertiary alkylamine may comprise one or more nitrogen and / or oxygen atoms and may therefore comprise, for example, one or more alcohol functional groups; mention may in particular be made of 2-amino-2-methylpropanol, triethanolamine, 2-(dimethylamino)propanol or 2-amino-2-(hydroxymethyl)-1,3-propanediol. Lysine or 3-(dimethylamino)propylamine may also be mentioned. Solvates that are acceptable for the compounds described in the present invention include conventional solvates, such as those formed during the final stage of preparation of said compounds due to the presence of solvents. Examples include solvates due to the presence of water or linear or branched alcohols, such as ethanol or isopropanol. Of course, according to the invention, a C-Glycoside corresponding to formula (I) can be used alone or in a mixture with other C-glycosides and in any proportion. A C-glycoside suitable for the invention can in particular be obtained by the synthesis process described in document WO 02 / 051828. Mention may in particular be made, by way of non-limiting illustration, of the C-glycoside compounds which are particularly suitable for the invention, the following compounds: - CBD-xylopyranoside-n-propane-2-one, - C-a-D-xylopyranoside-n-propane-2-one, - C-B-D-xylopyranoside-2-hydroxypropane, - C-a- D-xylopyranoside-2-hydroxypropane, - 1-(C-B-D-fucopyranoside)propane-2-one, - 1-(C-a-D-fucopyranoside)propan-2-one, - 1-(C-B-L-fucopyranoside)propane-2-one, - 1-(C-a-L-fucopyranoside)propane-2-one, - 1-(C-B-D-fucopyranoside)-2-hydroxypropane, - 1-(C-a-D-fucopyranoside)-2-hydroxypropane, - 1-(C-B-L-fucopyranoside)-2-hydroxypropane, - 1-(C-a-L-fucopyranoside)-2-hydroxypropane, - 1-(C-B-D-glucopyranosyl)-2-hydroxypropane, - 1-(C-a-D-glucopyranosyl)-2-hydroxypropane, - 1-(C-B-D-galactopyranosyl)-2-hydroxypropane, - 1-(C-a-D-galactopyranosyl)-2-hydroxypropane, - 1-(C-B-D-fucofuranosyl)propane-2-one, - 1-(C-a-D-fucofuranosyl)propane-2-one, - 1-(C-B-L-fucofuranosyl)propane-2-one, - 1-(CaL-fucofuranosyl)propane-2-one, - CBD-maltopyranoside-n-propane-2-one, - CaD-maltopyranoside-n-propane-2-one, - CBD-maltopyranoside-2-hydroxypropane, - CaD-maltopyranoside-2-hydroxypropane, their isomers and their mixtures. According to one embodiment, CBD-xylopyranoside-2-hydroxypropane or C- aD-xylopyranoside-2-hydroxypropane and better still C- BD-xylopyranoside-2-hydroxypropane can advantageously be used for the preparation of a composition according to the invention. In a specific embodiment, the C-glycoside may be C-fD-xylopyranoside-2-hydroxypropane (or hydroxypropyl tetrahydropyrantriol) provided as a solution containing 75% by weight of active ingredient in water and propylene glycol. In one embodiment, the composition of the present invention comprises hydroxypropyl tetrahydropyrantriol under the name MEXORYL SDL available from NOVEAL. Plant extracts Plant extracts that may be included in the composition of the present invention may include TUBER AESTIVUM EXTRACT, LEONTOPODUS ALPINUM CALLUS SEED EXTRACT, VITIS VINIFERA (GRAPE) SEED EXTRACT, PTEROCARPUS MARSUPIUM BARK EXTRACT, WINE EXTRACT, PYRUS MALUS (APPLE) SEED EXTRACT, FAGUS SYLVATICA BUD EXTRACT, HYDROLYZED ADANSONIA DIGITATATA EXTRACT, ARTEMIA EXTRACT, IRIS FLORENTINA ROOT EXTRACT, MILTIORRHIZA SALVIA EXTRACT, ARABICA COFFEE EXTRACT, or mixtures thereof. Plant extracts may also include Helianthus annulus extract such as Antiglyskin@ from Silab, wine extracts such as powdered white wine extract on a maltodextrin carrier sold as “Dehydrated white wine 2F” by Givaudan, a mixture of strawberry extract and marine glycogen such as Aglycal LS 8777® from Laboratoires Sériobiologiques, a black tea extract such as Kombuchka® from Sederma, or mixtures thereof. Plant extracts may also include Cassia alata leaf extract sold as DN-Age™ and / or lychee extract sold as Litchiderm™, a combination of Salvia miltiorhizza extract and niacinamide, sold as CollRepair™, Cichorium intybus extract sold as Lox-Age™, Achillea millefolium extract sold as Neurobiox™, Polygonum bistotta extract sold as Perlaura™, Alpinia galanga extract sold as Hyalufix™, corn extract sold as Deliner™, Voandzeia subterranea extract sold as Epigenist™, or mixtures thereof. In one embodiment, the composition of the present invention comprises a combination of niacinamide and Salvia miltiorrhiza leaf extract, under the trade name COLLREPAIR DG BC10036, available from BASF BEAUTY CARE SOLUTION. Peptides Peptides that may be included in the composition of the present invention may include the tripeptide glycine-histidine-lysine palmitoyl such as that sold under the name "Biopeptide CL" by the company Sederma; the hexapeptide valine-glycine-valine-alanine-proline-glycine palmitoyl such as that sold under the name "Biopeptide EL" by the company Sederma; the hexapeptide glutamic acid-glutamic acid-methionine-glutamic acid-arginine-arginine, the first (N-terminal) being acetylated and the last (C-terminal) being amidated, such as sold under the name Argireline by the company Lipotec; the pentapeptide lysine- threonine-threonine-lysine-serine sold in particular under the name "Matrixyl" by the company Sederma; the dipeptide NB-alanine-L-histidine as sold under the name "Carnoine" by the company Carlbiotech; carcinine hydrochloride (sold by Exsymol under the name "Austin"); palmitoyl tetrapeptide glycine-glutamine-proline-arginine, as sold under the name "Rigin" by the company Sederma; N-acetyl-tyrosine-arginine hexadecyl ester as sold under the name "Calmosensine" by the company Sederma; palmitoyl pentapeptide lysine-threonine-threonine-lysine-serine, as sold under the name "Palmitoyl-KTTKS" by the company Sederma; hexapeptide lysine-leucine-aspartic acid- alanine-proline-threonine, as sold under the name “Peptide Vinci 02” by the company Vincience; the hexapeptide glycine- proline-glutamine-glycine-proline-glutamine, as sold under the name “Collaxyl” by the company Vincience; argine and lysine polypeptides as sold under the name “Amadorine” by the company Solabia; N-acetyl-tyrosine-arginine hexadecyl ester, as sold under the name “Sensicalmine” by the company Sederma; glycine-histidine-lysine tripeptide in the form of a copper complex, such as that sold under the name “Hyamin” by the company Procyte; or mixtures thereof. In one embodiment, the composition of the present invention comprises palmitoyl tripeptides, palmitoyl tetrapeptides, carnosines or mixtures thereof. Flavonoids The flavonoid that may be included in the composition of the present invention may be a flavanone (2,3-dihydro-2-phenylchromen-4-one derivative). Flavones include: butin, eriodictyol, hesperetin, hesperidin, homoeriodictyol, isosakuranetin, naringenin, naringin, pinocembrin, poncirin, sakuranetin, sakuranin and sterubin. The flavonoid may be a flavanonol (2,3-dihydro-2-phenylchromen-4-one derivative). 3-hydroxy-2,3-dihydro-2-phenylchromen-4-one. Flavanols include: taxifolin, aromadedrin, chrysandroside A, chrysandroside B, xeractinol, astilbin, and fustin. Flavonoid can be a flavone (2-phenylchromen-4-one derivative). Flavones include: apigenin, luteolin, tangeritin, chrysin, baicalein, scutellarein, wogonin, synthetic flavones: diosmin and flavoxate. Flavonoid can be a flavonol (3-hydroxy-2-phenylchromen-4-one derivative). Flavonols include: 3-hydroxyflavone, azaleatin, fisetin, galangin, gossypetin, kaempferide, kaempferol, isorhamnetin, morin, myricetin, natsudaidain, pachypodol, quercetin, rhamnazine, rhamnetin, azalein, hyperoside, isoquercitin, kaempferitrin, myricitrin, quercitrin, robinin, rutin, spiraeoside, xanthorhamnin, amurensin, icariin, and troxerutin. The flavonoid may be a flavan-3-ol (2-phenyl-3,4-dihydro-2H-chromen-3-o1 derivatives). Flavan-3-ols include: catechin, epicatechin, epigallocatechin, epicatechin gallate, epigallocatechin gallate, epiafzelechin, fisetinidol, guibourtinidol, mesquitol, and robinetinidol.The flavonoid may be a flavan-4-ol (derived from 2-phenylchroman-4-ol). Flavan-4-ols include: apiforol and luteoforol. The flavonoid may be an isoflavone (derived from 3-phenylchromen-4-one). Isoflavones include: genistein, daidzein, Biochanin A, Formononetin, and the daidzein metabolite Equol. In one embodiment, the composition of the present invention comprises a combination of N-hydroxysuccinimide, Palmitoyl Tripeptide-1, Chrysin, Palmitoyl Tetrapeptide-7 and Biotin, under the trade name HALOXYL, available from SEDERMA (CRODA). Vitamin C and its derivatives The vitamin C that may be included in the composition of the present invention may have a D or L configuration, and the L configuration is preferably employed. Vitamin C is also called ascorbic acid and has the effect of inhibiting melanin production due to the powerful reducing effects of ascorbic acid. The ascorbic acid derivatives may be ascorbic acid salts, and the ascorbic acid salts are preferably selected from sodium ascorbate, magnesium ascorbyl phosphate, and sodium ascorbyl phosphate. The ascorbic acid derivatives may be ascorbic acid glycosides or ascorbic acid esters. Examples of ascorbic acid glycosides include, for example, ascorbyl glucoside. Examples of ascorbic acid esters include, for example, silyl ascorbate, tocopheryl ascorbate, and alkyl ascorbate.As alkyl ascorbate, methyl ascorbate or ethyl ascorbate is preferably used. In particular, ascorbyl glucoside is preferable. Ascorbic acid or its derivatives can be used alone or in combination with two or more of its types. Detailed examples of ascorbic acid derivatives include, for example, 5,6-di-O-dimethylsilyl ascorbate, which is commercially available under PRO-AA with Exsymol SAM; dl-phosphate alpha-tocopheryl-2-l-ascorbyl, which is commercially available as SVITAL EPC from Senju Pharmaceutical Co., Ltd.; sodium ascorbyl phosphate, which is commercially available as Stay-C 50 from Roche; ascorbyl glucoside, which is commercially available from Hayashibara Biochemical Labs., Inc.; 3-O-ethyl ascorbic acid; and the like. In one embodiment, the composition of the present invention comprises 3-O-ethyl ascorbic acid, under the trade name SPECWHITE VCE, available from SPECCHEM INDUSTRY. Hyaluronic acid and its salts The composition of the present invention may comprise hyaluronic acid, and / or one of its salts. Hyaluronic acid is a linear, non-sulfated glycosaminoglycan composed of repeating units of D-glucuronic acid and N-acetyl-D-glucosamine. According to the invention, the hyaluronic acid preferably has a number average molecular weight ranging from 500 Da to 10 MDa, and more particularly from 2 KDa to 2 MDa. Examples of hyaluronic acid suitable for the present invention include hyaluronic acids of animal origin, crosslinked or not, such as those marketed under the name Hylaform® by the company Genzyme, or hyaluronic acids of genetic origin including those intended for superficial, periorbital or perioral wrinkles, such as those marketed under the name Restylane Fine Lines® by the Q-Med laboratory, or intended for deep wrinkles, depressions of the lips and chin of the face, such as those marketed under the names Perlane® and Restylane Sub-Q® by the Q-Med laboratory. Preferably, examples of hyaluronic acid suitable for the present invention include those marketed under the name Restylane® by the Q-Med laboratory and under the name Surgiderm® by the Corneal laboratory. Also worth mentioning is low molecular weight hyaluronic acid (50 kDa) supplied by Evonik under the name Hyacare 50®, and sodium hyaluronate supplied by GIVAUDAN under the trade name RENOVHYAL LO (Mwz=20 to 50 kDa). Among the hyaluronic acid salts, mention may be made in particular of sodium salts, potassium salts, zinc salts, silver salts and mixtures thereof. More particularly, as examples of hyaluronic acid salts, mention may be made of potassium hyaluronate and sodium hyaluronate, preferably sodium hyaluronate. Preferably, the hyaluronic acid of the composition according to the invention is present in salified form, preferably in the form of sodium hyaluronate. In one embodiment, the active ingredients included in the composition of the present invention include PRO-XYLANETM and / or HALOXYLTM, and preferably PRO-XYLANETM, for example hydroxypropyl tetrahydropyrantriol under the name MEXORYL SDL available from NOVEAL. According to the present invention, the active ingredients are present in an amount ranging from about 0.01% by weight to about 40% by weight, preferably from about 0.1% by weight to about 20% by weight, or from about 1% by weight to about 10% by weight, relative to the total weight of the composition. Solvents Generally, the composition of the present invention comprises at least one solvent. Hereinafter, the term "solvent" in the present application does not include the above silicone oils. The solvent included in the composition of the present invention comprises one or more compounds miscible in water or at least partially miscible in water, in particular pure water. In one embodiment, the composition of the present invention does not comprise oil-soluble solvents or organic solvents other than the above silicone oils. In one embodiment, the solvent comprised in the composition of the present invention is water. Advantageously, the solvent is present in an amount ranging from about 25% by weight to about 90% by weight, preferably from about 30% by weight to about 85% by weight, or from about 40% by weight to about 80% by weight, relative to the total weight of the composition. Other ingredients The composition of the present invention may also comprise conventional cosmetic adjuvants or additives, for example, perfumes, preservatives (for example, chlorophenesin and phenoxyethanol) and bactericides, pH regulators (for example, citric acid), thickeners such as xanthan gum, and mixtures thereof. The skilled person can choose the amount of additional adjuvants or additives so as not to negatively impact the end use of the composition according to the present invention. Compositions In one embodiment, the composition of the present invention is preferably in the form of an oil-in-water emulsion. In one embodiment, the composition according to the present invention is a cosmetic composition for skin care, and in particular for skin care around the eyes. Preferably, the composition of the present invention is an anti-aging and anti- glycation. In one embodiment, the present invention relates to an anti-aging and anti-glycation composition, comprising silicone elastomers, including at least one emulsifying silicone elastomer, and at least one non-emulsifying silicone elastomer; at least one silicone oil; and more than one active agent, including water-soluble active ingredients, wherein the weight ratio of the emulsifying silicone elastomer to the non-emulsifying silicone elastomer is from about 1:35 to about 1:10, preferably from about 1:30 to about 1:15, or from about 1:28 to about 1:20. The silicone elastomers, silicone oils and active agents are defined above. In one embodiment, the present invention relates to an oil-in-water emulsion for skin care around the eyes, comprising silicone elastomers, including at least one emulsifying silicone elastomer, and at least one non-emulsifying silicone elastomer; and more than one anti-aging and anti-glycation active, including water-soluble active ingredients, the weight ratio between the emulsifying silicone elastomer and the non-emulsifying silicone elastomer ranging from about 1:35 to about |:10, preferably from about 1:30 to about 1:15, or from about 1:28 to about 1:20. The silicone elastomers, silicone oils and actives are defined above. In one embodiment, the present invention relates to an oil-in-water emulsion for skin care around the eyes, comprising silicone elastomers, including at least one emulsifying silicone elastomer, and at least one non-emulsifying silicone elastomer; and more than one anti-aging and anti-glycation active, including water-soluble active ingredients, the weight ratio of emulsifying silicone elastomer to non-emulsifying silicone elastomer ranging from about 1:30 to about 1:15, or from about 1:28 to about 1:20, the oil-in-water emulsion further comprising an amount of about 40% by weight to about 80% by weight of water, based on the total weight of the composition, and the actives include PRO-XYLANETM, Silicone elastomers, silicone oils and actives are defined above. According to the above embodiments, preferably, said at least one silicone oil comprises a first silicone oil and / or a second silicone oil, and the non-emulsifying silicone elastomer exists as a mixture with the first silicone oil before being added to the composition and / or the emulsifying silicone elastomer exists as a mixture with the second silicone oil before being added to the composition. More preferably, the silicone oil further comprises a third silicone oil, the third silicone oil being the same as or different from the first and / or second silicone oil. In one embodiment, the third silicone oil comprises one or more polyether-modified silicones and / or neither the first nor the second silicone oil comprises polyether-modified silicones. The first, second and third silicone oils together are defined as those mentioned in the “silicone oils” section. Still preferably, the third silicone oil is present in an amount ranging from about 0.1% by weight to about 20% by weight, preferably from about 1% by weight to about 15% by weight, or from about 2% by weight to about 10% by weight, e.g. about 5% by weight, based on the total weight of the composition. Combinations According to another aspect, the present invention relates to a combination for improving the feeling on the skin during and after the application of a cosmetic product, in particular the cosmetic product comprising anti-aging and anti-glycation actives, comprising, consisting substantially of, or even consisting of silicone elastomers, including at least one emulsifying silicone elastomer, and at least one non-emulsifying silicone elastomer; and at least one silicone oil, the weight ratio between the emulsifying elastomer and the non-emulsifying elastomer ranging from about 1:35 to about 1:10, preferably from about 1:30 to about 1:15, or from about 1:28 to about 1:20, and the actives are anti-aging and anti-glycation actives, including, consisting substantially of, or even consisting of, water-soluble active ingredients. The silicone elastomers, the silicone oils and the actives are defined above. Method and use According to another aspect, the present invention relates to a method of caring for the skin, in particular the skin around the eyes, by applying the composition of the present invention to the skin. In one embodiment, the process comprises the following steps in order, washing the skin, wiping the skin and applying the composition of the present invention to the skin, and optionally massaging the skin for about 2 seconds to about 20 seconds. In one embodiment, before or after applying the composition of the present invention to the skin, one or more compositions, for example those for skin care, skin whitening and sunscreen may also be applied. According to yet another aspect, the present invention relates to the use of a combination for improving the sensation on the skin during and after the application of a cosmetic product, in particular the cosmetic product comprising anti-aging and anti-glycation actives, wherein the combination comprises, consists sens- ably made of, or even consists of, silicone elastomers, including at least one emulsifying silicone elastomer, and at least one non-emulsifying silicone elastomer; and at least one silicone oil, and wherein the weight ratio of the emulsifying elastomer to the non-emulsifying elastomer is from about 1:35 to about 1:10, preferably from about 1:30 to about !:15, or from about 1:28 to about |:20, and the actives are anti-aging and anti-glycation actives including, substantially consisting of, or even consisting of water-soluble active ingredients. The silicone elastomers, silicone oils and actives are defined above. The present invention is illustrated in more detail by the examples described below, which are given by way of non-limiting illustrations. EXAMPLES The main raw materials used, trade names and their supplier are listed in Table 1. [Tables 1] [INCI Name [Trade Name | Supplier |AMMONIUM POLYACRYLOYL- |HOSTACERIN CLARIANT - |SHIN ETSU [Tables1] |INCI name [Commercial name | Supplier AMMONIUM POLYACRYLOYL- HOSTACERIN CLARIANT DIMETHYL TAURATE AMPS PEG-11 METHYL ETHER DI- |KF 351 A SHIN ETSU METHICONE (and) PPG-5-BUTETH-5 PEG-12 DIMETHICONE XIAMETER OFX- |DOW CORNING 0193 FLUID (DOW CHEMICAL) |DIMETHICONE (and) POLYSILICONE-11 |GRANSIL DMG- |GRANT IN- 6LC DUSTRIES DIMETHICONE (and) DIMETHICONE / |KSG-210 SHIN ETSU PEG-10 / 15 CROSSPOLYMER DIMETAUCLONE (and) DIMETAILONE ÉSSTEES PPS EISU |ee-1015 CROSSPOLYMER |DIMETHICONE (and) DIMETHICONOL |MIRASIL D-DML |ELKEM LV A2 SILICONES HYDROXYPROPYL TETRAHYDROPY-MEXORYL SDL |NOVEAL RANTRIOL 3-O-ETHYL ASCORBIC ACID SPECWHITE VCE | SPECCHEM INDUSTRY The compositions according to the inventive formula Ex.A and the comparative formulas EC. BD were prepared with the ingredients listed in Table 2 (the contents were expressed as percentages by weight of the ingredients relative to the total weight of each composition, unless otherwise indicated, and Table 2 only listed the main components of the compositions, and therefore the compositions may include other minor components): [Tables 2] Phas [Component [Ingredient Ex. |EC.B e AA |WATER Qs |Qs for |for 100 |100 |B |AMMONIUM [AMMONIUM 0.75 |0.75 C |PEG-I1 METHYL ETHER DI-METHICONE (and) PPG-5-BUTETH-5 PEG-12 DI-METHICONE |F |HYDROXYPRO HYDROXYP |25 |2.5 5 [0.105 [0.105 |0.105 |0.105 HYDROPYRAN [TRAHYDROP TRIOL YRANTRIOL 3-O-ETHYL 3-O-ETHYL |0.105|0.105 ASCORBIC ASCORBIC ACID ACID weight ratio between POLY- 26.88| / 26.88 [128 8.96 138.4 SILICONE-11 and DIMETHICONE / PEG-10 / 15 CROSSPOLYMER by calculation Note: PEG-11 METHYL ETHER DIMETHICONE (and) PPG-5-BUTETH-5: 90% peg-11 methyl ether dimethicone; 10% ppg-5-buteth-5 DIMETHICONE (and) DIMETHICONOL: 88% dimethicone; 12% dimethiconol DIMETHICONE (and) POLYSILICONE-11: 84% dimethicone, 16% polysilicone-11 DIMETHICONE (and) DIMETHICONE / PEG-10 / 15 CROSSPOLYMER: 25% dimethicone / peg-10 / 15 crosspolymer, 74.28% dimethicone, 0.5% dipropylene glycol, 0.2% sodium citrate, 0.02% tocopherol. Preparation procedure: The compositions were prepared as follows: 1). Adding phase A to the main boiler, continuing mixing at 75°C until all raw materials are dissolved into a clear liquid phase; 2). addition of phase B in the main boiler and use of a turbine to disperse it; 3). premixing of phases C+D to form a continuous fluid paste; 4). addition of phases C+D in the main boiler and mixing of materials; 5). addition of Phase F and mixing of materials. Performance of the compositions Sixteen female consumers aged 25 to 40 years with all skin types were recruited. They remained at room temperature (approximately 25°C) and applied the test samples to their eye area, then answered questionnaires to provide scores for skin adhesion, hydration, and soft film. [Table 3] 1 sensory comparison test: Ex. A EC.B Stickiness |2 14 Humidity [13 3 Flexible film [5 qe The data in Table 3 show that the composition of EC. B did not include emulsifying elastomers, in which 14 individuals felt that EC. B had a stickier feel on the skin than Ex. A, while 13 individuals felt that Ex. A provided a more moisturized skin finish and 15 individuals felt that Ex. A provided a soft film. It can therefore be seen that the composition of Ex. A effectively improved the skin feel due to less stickiness, better moisturization and soft film property of the compositions, compared to the compositions that did not include emulsifying elastomers. [Table 4] 2nd sensory comparison test: Stickiness Humidity Soft film ES EN From the data in Table 4, it can be seen that the composition of EC. C did not include any additional silicone oils other than those in the blend with the elastomers, while 12 people felt that EC. C had a stickier feel on the skin than Ex. A while 11 people felt that Ex. A provided a more moisturized skin finish and 10 people felt that Ex. A provided a soft film. It can therefore be seen that the composition of Ex. A effectively improved the skin feel due to less stickiness, more moisture and a soft film property of the compositions, compared to the compositions that did not include additional silicone oils. [Table 5] 3rd sensory comparison test: Stickiness Humidity Soft film From the data in Table 5, it could be seen that the composition of EC. D included a lower amount of non-emulsifying elastomer than Ex. A, in which 15 people felt that EC. D had a stickier skin feel than Ex. A, while 13 people felt that Ex. A provided a finish of more hydrated skin and 12 people felt that Ex. A provided a soft film. It can therefore be seen that the composition of Ex. A effectively improved the skin feel with less stickiness, more hydration and a soft film property of the compositions, compared to the compositions which did not include the specific ratio of non-emulsifying elastomer to emulsifying elastomer of the present invention. [Table 6] 4th sensory comparison test: Ex. A Stickiness |4 Humidity 12 Flexible film E From the data in Table 6, it could be seen that the composition of EC. E included a larger amount of emulsifying elastomer than that of Ex. A, where 12 people felt that EC. E had a stickier skin feel than Ex. A, while 12 people felt that Ex. A provided a more moisturized skin finish and 13 people felt that Ex. A provided a soft film. It can therefore be seen that the composition of Ex. A effectively improved the skin feel with less stickiness, more moisture and a soft film property of the compositions, compared to the compositions which did not include the specific ratio of non-emulsifying elastomer to emulsifying elastomer of the present invention. [Table 7] Fifth sensory comparison test: Ex. At EC.F Stickiness |6 The [10 Humidity 10 6 Flexible film | …a From the data in Table 7, it could be seen that the composition of EC. F included a larger amount of non-emulsifying elastomer than that of Ex. A, where 10 people felt that EC. F had a stickier skin feel than Ex. A, while 10 people felt that Ex. A provided a more moisturized skin finish and 12 people felt that Ex. A provided a soft film. It can therefore be seen that the composition of Ex. A effectively improved the skin feel with less stickiness, more moisture and a soft film property of the compositions, compared to the compositions that did not include the ratio specific between the non-emulsifying elastomer and the emulsifying elastomer of the present invention. Furthermore, when formulating the composition of EC. F, it was found that this composition provided even greater volume and therefore it was difficult to spread this composition.

Claims

Claims

1. Composition for caring for keratinous material, in particular composition anti-aging and anti-glycation, preferably in the form of a oil-in-water emulsion, comprising (a) silicone elastomers, including (al) at least one emulsifying silicone elastomer, and {a2) at least one non-emulsifying silicone elastomer; {b) at least one silicone oil; and {c) at least one active, which preferably includes active ingredients soluble in water, in which the weight ratio between the silicone elastomer emulsifier and non-emulsifying silicone elastomer ranges from 1]:35 to 1:10, preferably from 1:30 to 1:15, or from 1:28 to 1:

20.

2. Composition according to claim 1, wherein said at least one silicone oil includes a first silicone oil and / or a second silicone oil, and non-emulsifying silicone elastomer is present as a mixture with the first silicone oil before being added to the composition and / or silicone elastomer emulsifier is present as a mixture with the second oil of silicone before being added to the composition; said at least one silicone oil further includes a third silicone oil, and the third silicone oil is identical to the first and / or second silicone oil or different from both.

3. A composition according to claim 1 or 2, wherein the elastomer of silicone emulsifier is chosen from silicone elastomers comprising at least one oxyalkylenated chain and / or at least one glyceryl chain; is preferably selected from the group consisting of dimethicone / PEG-10 dimethicone vinyl dimethicone crosslinked polymer, PEG-10 dimethicone crosslinked polymer, of a di- crosslinked polymer methicone / PEG-10 / 15, PEG-15 / lauryl dimethicone crosslinked polymer, PEG-15 / lauryl polydimethylsiloxyethyl dimethicone crosslinked polymer, PEG-12 dimethicone cross-linked polymer, dimethicone cross-linked polymer / polyglycerin-3, lauryl dimethicone / polyglycerin-3 cross-linked polymer and their mixtures.

4. Composition according to any one of the preceding claims, wherein the non-emulsifying silicone elastomer is selected from the group consisting of crosslinked polymer of dimethicone, polymer vinyl dimethicone crosslinked, dimethicone / vinyl crosslinked polymer dimethicone, dimethicone-3 crosslinked polymer and mixtures thereof.

5. A composition according to any preceding claim, in which the set of the first, second and third oils of silicones are chosen from linear, branched or cyclic, optionally modified with at least one fraction or organofunctional group, including polyether-modified silicones; preferably, are chosen from the group consisting of dimethicones, di- methiconols, PEG-10 methyl ether dimethicone, PEG-11 methyl ether dimethicone, PEG-32 methyl ether dimethicone, PEG / PPG-18 / 18 di- methicone, PEG / PPG-19 / 19 dimethicone, PEG / PPG-20 / 20 dimethicone, PEG / PPG-20 / 22 butyl ether dimethicone, PEG / PPG-30 / 10 dimethicone, PEG-9 dimethicone, PEG-10 dimethicone, PEG-12 dimethicone, and their mixtures.

6. Composition according to any one of the preceding claims, wherein the active ingredient is selected from the group consisting of compounds of C-Glycoside, plant extracts, peptides, flavonoids, vitamin C and its derivatives, hyaluronic acid and its salts, and mixtures thereof; preferably, is selected from the group consisting of Tuber extract Aestivum, cultured extract of Leontopodium Alpinum Callus, carnosines, Salvia Miltiorrhiza leaf extract, polypeptides or oli- gopeptides, niacinamides, chrysins, biotins, hydroxypropyl tetrahy- dropyrantriols, ascorbic acids, hyaluronic acid and / or hyaluronate of sodium, and mixtures thereof.

7. Composition according to any one of the preceding claims, wherein the emulsifying silicone elastomer is present in a amount ranging from 0.01 wt% to 5 wt%, preferably 0.1 wt% weight to 3% by weight, or from 0.2% by weight to 2% by weight, relative to the total weight of the composition.

8. Combination for improving skin sensation during and after the application of a cosmetic, comprising, consisting substantially of, or even consisting of (a) silicone elastomers, including (al) at least one emulsifying silicone elastomer, and (a2) at least one non-emulsifying silicone elastomer, and (b) at least one silicone oil, and in which the weight ratio between the emulsifying elastomer and the non-emulsifying elastomer varies from 1:35 to 1:10, preferably 1:30 to 1:15, or 1:28 to 1:20, and the asset preferably includes water-soluble active ingredients.

9. A combination according to claim 8, wherein the elastomer of silicone emulsifier is chosen from silicone elastomers comprising at least one oxyalkylenated chain and / or at least one glyceryl chain; is preferably selected from the group consisting of dimethicone / PEG-10 dimethicone vinyl dimethicone crosslinked polymer, PEG-10 dimethicone cross-linked polymer, dimethicone cross-linked polymer / PEG-10 / 15, crosslinked polymer PEG-15 / auryl dimethicone, polymer crosslinked PEG-15 / lauryl polydimethylsiloxyethyl dimethicone polymer crosslinked PEG-12 dimethicone, crosslinked dimethicone / poly- glycerin-3, lauryl dimethicone / polyglycerin-3 crosslinked polymer and their mixtures, and / or the non-emulsifying silicone elastomer is chosen in the group consisting of dimethicone crosslinked polymer, vinyl dimethicone crosspolymer, dimethicone crosspolymer / vinyl dimethicone, dimethicone-3 crosslinked polymer, and their mixtures.

10. A combination according to claim 8 or 9, wherein the oil of silicone is chosen from linear, branched or cyclic silicones, optionally modified with at least one moiety or organo- non-functional, including polyether-modified silicones; preferably, is selected from the group consisting of dimethicones, dimethiconols, PEG-10 methyl ether dimethicone, PEG-11 methyl ether dimethicone, PEG-32 methyl ether dimethicone, PEG / PPG / 18 / 18 dimethicone, PEG / PPG-19 / 19 dimethicone, PEG / PPG-20 / 20 dimethicone, PEG / PPG-20 / 22 butyl ether dimethicone, PEG / PPG-30 dimethicone, PEG-9 di- methicone, PEG-10 dimethicone, PEG-12 dimethicone and their mixtures.